LDLR Gene

Introduction

Ldlr Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Pathway Diagram

flowchart TD
    LDLR["LDLR"]
    style LDLR fill:#006494,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0
    LDL["LDL"]
    LDLR -->|"regulates"| LDL
    familial_hypercholesterolemia["familial hypercholesterolemia"]
    LDLR -->|"causes"| familial_hypercholesterolemia
    LDL_cholesterol["LDL cholesterol"]
    LDLR -->|"regulates"| LDL_cholesterol
    cardiovascular_disease["cardiovascular disease"]
    LDLR -->|"contributes to"| cardiovascular_disease
    cholesterol_metabolism["cholesterol metabolism"]
    LDLR -->|"participates in"| cholesterol_metabolism
    APOE["APOE"]
    LDLR -->|"activates"| APOE
    Als["Als"]
    LDLR -->|"inhibits"| Als
    Lipid_Metabolism["Lipid Metabolism"]
    LDLR -->|"regulates"| Lipid_Metabolism
    PCSK9["PCSK9"]
    PCSK9 -->|"inhibits"| LDLR
    h_b948c32c["h-b948c32c"]
    h_b948c32c -->|"therapeutic target"| LDLR
    h_9d29bfe5["h-9d29bfe5"]
    h_9d29bfe5 -->|"therapeutic target"| LDLR
    statins["statins"]
    statins -->|"activates"| LDLR
    MAFF["MAFF"]
    MAFF -->|"regulates"| LDLR
    h_b948c32c -->|"targets gene"| LDLR
    h_9d29bfe5 -->|"targets gene"| LDLR
    IDOL["IDOL"]
    IDOL -->|"inhibits"| LDLR
    style LDL fill:#4a1a6b,stroke:#ce93d8,color:#e0e0e0
    style familial_hypercholesterolemia fill:#ef5350,stroke:#ef5350,color:#e0e0e0
    style LDL_cholesterol fill:#ef5350,stroke:#ff8a65,color:#e0e0e0
    style cardiovascular_disease fill:#ef5350,stroke:#ef5350,color:#e0e0e0
    style cholesterol_metabolism fill:#5d4400,stroke:#ffd54f,color:#e0e0e0
    style APOE fill:#1b5e20,stroke:#81c784,color:#e0e0e0
    style Als fill:#ef5350,stroke:#ef5350,color:#e0e0e0
    style Lipid_Metabolism fill:#5d4400,stroke:#ffd54f,color:#e0e0e0
    style PCSK9 fill:#4a1a6b,stroke:#ce93d8,color:#e0e0e0
    style h_b948c32c fill:#006494,stroke:#888,color:#e0e0e0
    style h_9d29bfe5 fill:#006494,stroke:#888,color:#e0e0e0
    style statins fill:#006494,stroke:#4fc3f7,color:#e0e0e0
    style MAFF fill:#4a1a6b,stroke:#ce93d8,color:#e0e0e0
    style IDOL fill:#4a1a6b,stroke:#ce93d8,color:#e0e0e0

Overview

The LDLR (Low-Density Lipoprotein Receptor) is a cell surface receptor responsible for the uptake of LDL cholesterol into cells via receptor-mediated endocytosis. It plays a crucial role in maintaining plasma cholesterol homeostasis, and LDLR dysfunction leads to familial hypercholesterolemia (FH), characterized by elevated LDL levels and premature cardiovascular disease. Beyond its well-established role in peripheral cholesterol metabolism, LDLR has emerged as an important player in Alzheimer’s disease and cerebrovascular pathology, influencing amyloid-beta (Aβ) clearance and cerebral amyloid angiopathy (CAA).^{6LDL receptor fluctuations in health and disease: lessons from a century of research2009 · PMID 19240241Open reference}

Gene Structure

The LDLR gene consists of:

• 18 exons spanning approximately 45 kb on chromosome 19p13.2

• Alternative splicing produces multiple isoforms

• Strong transcriptional regulation by sterol regulatory element-binding proteins (SREBPs)

Promoter Structure

• Contains SRE (sterol regulatory element) for cholesterol-responsive regulation

• Multiple transcription factor binding sites

• Responsive to statins via SREBP activation

Protein Structure

The LDLR is a modular transmembrane protein with distinct domains:

Extracellular Domain (1-699)

1. Ligand-binding repeats (7): Each contains conserved cysteine-rich sequences

2. Epidermal growth factor (EGF) precursor homology domain: 3 EGF-like repeats

3. O-linked sugar domain: Variable length

4. Trimeric beta-propeller: Facilitates ligand release in endosomes

Transmembrane Domain (700-722)

• Single-pass transmembrane helix

• Anchors receptor in plasma membrane

Cytoplasmic Tail (723-860)

• NPxY motif: Essential for clathrin-mediated endocytosis

• FDNPVY motif: Required for internalization

• Ser/Thr phosphorylation sites: Regulate trafficking

Normal Function

Cholesterol Homeostasis

LDLR mediates cellular uptake of LDL particles:^{1A tribute to Michael S2009 · PMID 19141427Open reference}

1. LDL Binding: Extracellular domain binds circulating LDL (containing cholesterol and triglycerides)

2. Clathrin-Mediated Endocytosis: Internalization via coated pits

3. Endosomal Acidification: Low pH triggers LDL release from receptor

4. Receptor Recycling: LDLR returns to surface; LDL delivered to lysosomes

5. Cholesterol Utilization: Free cholesterol used for membrane synthesis, steroidogenesis

Regulatory Mechanisms

• Negative feedback: High intracellular cholesterol reduces LDLR expression

• Statin effect: Statins upregulate LDLR via SREBP activation

• PCSK9 regulation: PCSK9 binding targets LDLR for degradation

Expression Pattern

Peripheral Tissues

• Liver: Highest expression - primary LDL clearance organ

• Adrenal glands: Cholesterol for steroid synthesis

• Ovaries: Cholesterol for steroid hormone production

• Intestine: Minor contribution to cholesterol absorption

Brain Expression

In the central nervous system, LDLR is expressed in:^{2Neuronal LDL receptor-related protein 1 (LRP1) regulates amyloid-beta clearance2012 · PMID 22903161Open reference}

• Neurons: Pyramidal neurons in cortex and hippocampus

• Astrocytes: Regulate brain cholesterol homeostasis

• Microglia: Cholesterol clearance in inflammatory states

• Brain vasculature: Endothelial cells of the BBB

Disease Associations

Familial Hypercholesterolemia (FH)

Heterozygous FH (1 in 500) and homozygous FH (1 in 1 million):^{3Lipid disorders2014 · PMID 25099581Open reference}

• Caused by LDLR mutations (over 2000 identified)

• Types:

  • FH type I: Receptor absent (null)

  • FH type II: Receptor defective binding

  • FH type III: Recycling defect

  • FH type IV: Internalization defect

  • FH type V: Transport defect

Clinical features:

• Elevated LDL-C ( > 330 mg/dL heterozygous)

• Tendon xanthomas

• Premature coronary artery disease

• Arcus corneae

Treatment: Statins, ezetimibe, PCSK9 inhibitors, LDL-apheresis, gene therapy

Alzheimer’s Disease

LDLR plays complex roles in AD:^{4Apolipoprotein E and LDLR in Alzheimer's disease2016 · PMID 27589516Open reference}

• Aβ clearance: LDLR mediates neuronal Aβ uptake and clearance

• Cholesterol-Aβ link: LDLR dysfunction affects brain cholesterol and Aβ metabolism

• Genetic association: LDLR polymorphisms modify AD risk

• Therapeutic target: LDLR modulators may enhance Aβ clearance

• APOE interaction: LDLR regulates APOE lipidation status

Cerebral Amyloid Angiopathy (CAA)

• LDLR dysfunction impairs Aβ clearance from cerebral vessels

• Contributes to CAA development

• Increases hemorrhagic stroke risk

Stroke

• LDLR variants associated with stroke risk

• Atherosclerosis of cerebral vessels

• Interaction with other vascular risk factors

Molecular Mechanisms

LDLR in Aβ Metabolism

Signaling Pathways

• SREBP2: Master regulator of LDLR transcription

• PCSK9: Induces LDLR degradation

• IDOL: Induces LDLR degradation

• ERK/MAPK: Regulates LDLR function

Therapeutic Implications

Current Therapies

AD Therapeutic Strategies

• LDLR agonists: Enhance Aβ clearance

• Gene therapy: AAV-LDLR delivery to brain

• Small molecule modulators: Target LDLR trafficking

• Combination approaches: With anti-amyloid antibodies

Emerging Approaches

• CRISPR-Cas9: Correct LDLR mutations in hepatocytes

• mRNA therapeutics: Deliver functional LDLR mRNA

• Brain-penetrant modulators: Target CNS LDLR

Animal Models

• LDLR knockout mice: Hypercholesterolemia, atherosclerosis

• Humanized LDLR: Expressing human LDLR in mice

• Transgenic AD models: LDLR manipulation in amyloid models

See Also

• LDLR Protein

• APOE Gene - Major AD risk gene, interacts with LDLR

• PCSK9 Gene - LDLR regulator

• Familial Hypercholesterolemia

• Alzheimer’s Disease

• Lipid Metabolism in Neurodegenerationmechanisms/sphingolipid-metabolism)

• Cerebral Amyloid Angiopathy

• Atherosclerosis

External Links

• NCBI Gene: LDLR

• UniProt: LDLR

• OMIM: LDLR

• GeneCards: LDLR

• LDLR Database

Background

The study of Ldlr Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.